JILLIAN BARNETTE: Open Payments
NPI 1487108239 · NORTHPORT, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 35 payments from 12 companies in 2025. Trend: 2023 $389 · 2024 $255 · 2025 $740
Food & beverage: $663Education: $77
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $160 |
| ABBVIE INC. | 9 | $141 |
| Amgen Inc. | 5 | $92 |
| Janssen Biotech, Inc. | 1 | $77 |
| UCB, Inc. | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $53 |
| Genentech USA, Inc. | 2 | $46 |
| ANI Pharmaceuticals, Inc. | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| Radius Health, Inc. | 1 | $23 |
Products named: COSENTYX, RINVOQ, TREMFYA, KRYSTEXXA, Bimzelx, OFEV, TAVNEOS, PURIFIED CORTROPHIN GEL.
Industry payments across AL — which companies pay providers there.
